The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U. In seeking to track the performance of the S&P Biotechnology Select In... The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI). 詳細を表示
State Street Global Advisors (SSGA) announced today that the SPDR® S&P Biotech ETF (NYSE: XBI), received payment as an authorized claimant from a class action settlement related to Human...
NEW YORK, March 2 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) announced today it listed five new exchange traded funds (ETFs) issued by three separate issuers in February, bringing...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.9699 | 2.20420722838 | 89.37 | 92.845 | 89.37 | 6573307 | 91.82334251 | SP |
4 | -8.4401 | -8.45870916015 | 99.78 | 100.2 | 88.63 | 7951203 | 94.68710595 | SP |
12 | -6.2701 | -6.42362462862 | 97.61 | 105.47 | 88.63 | 8257606 | 96.71075285 | SP |
26 | -1.0501 | -1.13659486957 | 92.39 | 105.47 | 88.63 | 7807358 | 97.40753586 | SP |
52 | 0.9799 | 1.08444001771 | 90.36 | 105.47 | 81.14 | 9133462 | 93.95145021 | SP |
156 | -26.0401 | -22.1844436872 | 117.38 | 117.57 | 61.78 | 10029305 | 85.39599877 | SP |
260 | -6.6401 | -6.77699530516 | 97.98 | 174.79 | 61.78 | 8438708 | 94.56196285 | SP |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約